Keros Therapeutics, Inc. financial data

Symbol
KROS on Nasdaq
Industry
Pharmaceutical Preparations
Location
1050 Waltham Street, Suite 302, Lexington, Massachusetts
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.91K % +0.91%
Debt-to-equity 9.24 % +16.8%
Return On Equity -45.5 % -6.16%
Return On Assets -41.7 % -4.88%
Operating Margin -113K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 36.1M shares +22%
Common Stock, Shares, Outstanding 36.1M shares +22.1%
Entity Public Float 905M USD +92.3%
Common Stock, Value, Issued 3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 35.7M shares +25.8%
Weighted Average Number of Shares Outstanding, Diluted 35.7M shares +25.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 83K USD
Research and Development Expense 142M USD +42%
General and Administrative Expense 37.4M USD +27.7%
Operating Income (Loss) -180M USD -38.6%
Nonoperating Income (Expense) 19.3M USD +45.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -153M USD -46.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -160M USD -37.8%
Earnings Per Share, Basic -5.15 USD/shares -17%
Earnings Per Share, Diluted -5.15 USD/shares -17%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 442M USD +25.9%
Accounts Receivable, after Allowance for Credit Loss, Current 226K USD
Other Assets, Current 616K USD +19.6%
Assets, Current 463M USD +27.9%
Property, Plant and Equipment, Net 4.43M USD +51.2%
Operating Lease, Right-of-Use Asset 15M USD -8.37%
Other Assets, Noncurrent 2.05M USD +29.1%
Assets 486M USD +26.4%
Accounts Payable, Current 4.99M USD +6.49%
Employee-related Liabilities, Current 3.93M USD +42.3%
Accrued Liabilities, Current 12.7M USD +17.7%
Liabilities, Current 18.7M USD +21.1%
Operating Lease, Liability, Noncurrent 13.2M USD -6%
Liabilities 31.9M USD +8.22%
Retained Earnings (Accumulated Deficit) -425M USD -60.7%
Stockholders' Equity Attributable to Parent 454M USD +27.9%
Liabilities and Equity 486M USD +26.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -44.6M USD -30.2%
Net Cash Provided by (Used in) Financing Activities 157M USD +45.6%
Net Cash Provided by (Used in) Investing Activities -946K USD +10.9%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 36.1M shares +22.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 111M USD +53.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 444M USD +25.8%
Deferred Tax Assets, Valuation Allowance 99.4M USD +63.9%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 103M USD +58.9%
Operating Lease, Liability 14.4M USD +8.88%
Depreciation 277K USD +65.9%
Payments to Acquire Property, Plant, and Equipment 946K USD -10.9%
Lessee, Operating Lease, Liability, to be Paid 21.4M USD +5.86%
Property, Plant and Equipment, Gross 5.85M USD +83.9%
Operating Lease, Liability, Current 1.05M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.5M USD +13.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.43M USD +39.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.92M USD +0.06%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.58M USD
Deferred Tax Assets, Operating Loss Carryforwards 36.2M USD -3.83%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 0 USD
Preferred Stock, Shares Authorized 10M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.58M USD +10.3%
Operating Lease, Payments 1.12M USD +22.9%
Additional Paid in Capital 878M USD +41.9%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 0 USD
Current Federal Tax Expense (Benefit) 0 USD
Deferred Tax Assets, Net of Valuation Allowance 3.66M USD -13.2%
Share-based Payment Arrangement, Expense 31.1M USD +55.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares